HOME >> MEDICINE >> NEWS
Common C-section method leads to unnecessary scars, Stanford study finds

STANFORD, Calif. - A controversial surgical procedure that has lost favor among medical professionals may benefit women who have had caesarean sections. So say researchers at the Stanford University School of Medicine, who have found that closing the parietal peritoneum, a multi-layered membrane that lines the abdomino-pelvic walls, substantially decreases the likelihood of scarring that can make future C-sections more difficult.

The finding on this link between peritoneum closure and fewer adhesions (scars that form abnormal connections between two parts of the body) runs contrary to current literature on the drawbacks of the procedure in non-pregnant women and contrary to current thinking among many surgeons.

"This was a surprise finding," said Deirdre Lyell, MD, assistant professor of obstetrics and gynecology and lead author of a paper appearing in the August issue of Obstetrics and Gynecology. "We were fully expecting to find that closing the peritoneum at caesarean delivery would increase adhesions."

More than 1 million caesareans - just over 27 percent of all births in the United States-are performed each year. However, Lyell said there is a lack of literature on the long-term impact of various parts of the procedure, including the closure of a woman's peritoneum following delivery. When c-sections are performed, surgeons must cut through the parietal peritoneum layer. The question plaguing Lyell was whether it is better to close it at the end of the caesarean or allow the membrane to heal on its own.

"There is surprisingly little data on the best way to perform c-sections," said Lyell, who is also part of the Johnson Center for Pregnancy and Newborn Services at Lucile Packard Children's Hospital.

Although the tradition had been to close the peritoneum following delivery, recent short-term studies have linked such closures with increased operation time and postoperative pain. There has also been co
'"/>


1-Aug-2005


Page: 1 2 3

Related medicine news :

1. Commonly used drug offers promise for premature babies
2. Commonly used pain medications do not prevent Alzheimers disease
3. Common anesthetic may induce cell death, generation of Alzheimers-associated protein
4. Common blood pressure drug treats muscular dystrophy in mice
5. Common PTSD drug is no more effective than placebo
6. Common cold may be just a fingertip away due to environmental contamination
7. Commonwealth Fund commission says the US health care system needs thorough transformation
8. Commonly recommended sedative does not improve infant sleep
9. Common asthma inhaler causing deaths, researchers assert
10. Common painkillers associated with increased risk of first hospital admission for heart failure
11. Commonly used blood pressure medication prevents aortic aneurysm in mice with Marfan syndrome

Post Your Comments:
(Date:8/30/2015)... Fl (PRWEB) , ... August 30, 2015 , ... Natural ... have beneficial effects as sleep aids and calming remedies, which help to improve mood ... result of a great deal of research in the field of regenerative medicine conducted ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College ... serve as the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who ... help the college expand its reach and impact through innovative technologies and strategies. , ...
(Date:8/29/2015)... , ... August 29, 2015 , ... ... insufficient scrotal support and protection against dribbled urine and sweat. "In order to ... Hills, N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over ... preset contains 15 seconds of unique footage that users can shrink and stretch in ... attract and more. Users can customize color, brightness, scale, speed, range, and flare attributes ...
(Date:8/28/2015)... (PRWEB) , ... August 29, 2015 , ... Rio ... higher learning and the student experience as part of the EDUCAUSE - Next Generation ... Foundation . , This is the third Breakthrough Models Incubator hosted by ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ) ... on China,s Bevacizumab Market ,2010-2019" report to their ... name of Avastin, bevacizumab injection is the first angiogenesis ... approved by CFDA to treat metastatic colorectal cancer. Currently, ... all come from Roche and its subsidiary Genectech. In ...
(Date:8/28/2015)... 2015 Patterson Medical, formerly the medical ... ), is now an independent company with today,s ... Medical by Madison Dearborn Partners (MDP).  ... a transition period before rebranding as the world,s ... products.  With the focused resources and expertise of ...
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... ranibizumab was approved by CFDA to treat wet age- ... a product of Novartis, is available in the Chinese ... developed drug for the treatment of wet AMD in ...
Breaking Medicine Technology:Investigation Report on China's Bevacizumab Market 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Investigation Report on China's Ranibizumab Market, 2012-2019 2
Cached News: